Last month, a multidisciplinary panel led by the Infectious Diseases Society of America, the American Academy of Neurology, and the American College of Rheumatology published the 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease in Clinical Infectious Diseases.
The authors say it provides recommendations aimed to serve as a meaningful resource for the safe, effective, evidence-based care of people with Lyme disease.
Here to give her views on the guidelines is attorney and the Chief Executive Officer of LymeDisease.org, Lorraine Johnson, JD, MBA.
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease
- LymeDisease.org’s Lorraine Johnson discusses MyLymeData and a new NSF grant
- Lyme disease treatment: Some thoughts
- The history behind the Lyme disease controversy and what’s new in Lyme research
- A look at the differences in geographical distribution of Lyme disease
- A new Lyme disease test: Dr Richard Marconi discusses the GLD Test
- Lyme disease, Stevia and the quest for better treatments
- Lyme disease: Borrelia biofilm in the body demonstrated
- Lyme disease: The Borrelia mayonii discovery
- Powassan virus: The spread is inevitable